Quantcast
Wednesday, December 4, 2019

AstraZeneca sells U.S., Canada commercial rights to mental health drug Seroquel

AstraZeneca is selling the commercial rights to Seroquel and Seroquel XR (extended-release) in the US and Canada to German-based Cheplapharm Arzneimittel GmbH (Cheplapharm).  Ruud Dobber, executive vice president, BioPharmaceuticals Business Unit, said: “This divestment supports our strategy...

AZ gets fast-track Priority Review for lung cancer drug

The US Food and Drug Administration (FDA) has granted Priority Review for Imfinzi (durvalumab) for the treatment of patients with previously untreated extensive-stage small-cell lung cancer. Small-cell lung cancer is an aggressive, fast-growing form of...

Incyte gets fast-track review for drug aimed at treating rare type of bile duct...

The U.S. Food and Drug Administration (FDA) has accepted Priority Review its New Drug Application (NDA) for Incyte's pemigatinib as a treatment for a type of a rare type of bile duct cancer.  “There is...

Release from Delaware Division of Public Health regarding TB report

  Editor's note: The following was released by the Delaware Division of Public Health after a News Journal report on  tuberculosis)   As a reminder, Delaware has strict privacy laws related to TB, therefore DPH will not be...

Division of Public Health adds more detailed info to Healthy Community data...

The Division of Public Health (DPH) announced updates to its My Healthy Community data portal. DPH launched My Healthy Community earlier this year to allow Delawareans to access information about the overall health of their...

European regulators approve AstraZeneca diabetes medicine

AstraZeneca  announced that the European Commission (EC) approved Qtrilmet(metformin hydrochloride, saxagliptin, and dapagliflozin) modified-release tablets to improve glycaemic control in some adults with type-2 diabetes. Across the trials, the combination of Forxiga, Onglyza, and metformin fared...

State lung cancer rate remains high, but survival rates continue to climb

Lung cancer survival rates continue to increase, according to a new report from the American Lung Association.  While it’s estimated that 840 Delaware residents will be diagnosed with this disease in 2019 alone, more people than ever...

Newark Manor agrees to $381,000 settlement in case brought by state

Newark Manor Nursing Home (also known as Premiere Healthcare, Inc.), its owner Bruce Boyer, administrator David Boyer and former administrator Susan Comegys have agreed to a $381,000 settlement with the State of Delaware. Newark Manor...

Enrollment underway for marketplace health insurance

Enrollment is underway at Delaware’s Health Insurance Marketplace. The enrollment comes after a 19 percent drop in rates for Affordable Care Act coverage. The insurance is available for people who are not covered by an...

Incyte net income soars in third quarter, nine months of 2019

Incyte Corp  reported sharply higher net income in the third quarter and first nine months of 2019. The pharmaceutical company is based near Wilmington. On Tuesday, Incyte shares were up more than 4 percent to...